Eyes a haven for Ebola and other viruses
22 June, 2022A specific cell within our retina appears to be particularly good at housing Ebola and other viruses, according to research based on cells from donated human eyes.
Study explores hospital bacteria's ability to change
27 May, 2022Flinders University researchers are exploring hospital strain of Acinetobacter baumannii and its cellular response to important antibiotic colistin.
NSW reports 'probable' case of monkeypox
23 May, 2022A 40-year-old traveller recently returned from Europe has been identified as a probable case of monkeypox, with confirmatory testing underway.
Respiratory syncytial virus behind 100,000 child deaths
23 May, 2022There were over 45,000 deaths in infants under six months old in 2019, with one in five of the total global cases of RSV occurring in this age group.
Model finds key to COVID-19 deaths in the elderly
20 May, 2022A person's ability to fight infections largely depends on how well their immune system replicates the cells effective at destroying the virus that causes the disease.
Long COVID: Half of patients hospitalised have at least one symptom two years on
18 May, 2022Half of a a group of patients admitted to the hospital with COVID-19 infection in Wuhan, China, still have at least one lingering symptom two years on, according to a new study.
Raw meat parasite linked to common eye disease
13 May, 2022One in 150 Australians have retinal scars caused by the Toxoplasma parasite, according to new Flinders University analysis.
Study explores AMR bacteria presence in supermarket meat
09 May, 2022New report claims there is an alarming proportion of antimicrobial resistant bacteria in packaged beef and salmon from Australian supermarkets.
Good IPC programs can reduce infections by 70% — WHO
09 May, 2022Recent disease outbreaks have highlighted how healthcare settings can contribute to the spread of infections, if insufficient attention is paid to infection prevention and control.
800 Victorians sought for COVID-19 booster shot trial
09 May, 2022The CEPI and the MCRI are inviting participation for a global trial investigating whether vaccinating people with a lower COVID-19 booster dose is just as effective as a full dose, but with fewer side effects.
Hepatitis cases of unknown origin raise concerns
02 May, 2022More than 11 countries around the world, including the US, UK, Spain, Israel, Denmark, Norway and France among other countries, have reported acute, severe hepatitis of unknown origin.
Australian innovation delivering standardised frontline ultrasound infection prevention
01 May, 2022In Australia, patients will suffer from an estimated 165,000 healthcare-associated infections (HAIs) each year.
New coating for implants, medical devices cuts infection risk
29 April, 2022Infections after hip replacements and from orthopaedic device procedures can be complicated and lead to painful and repeat surgeries.
Drug-resistant environmental mould causes lung infections
27 April, 2022Drug-resistant mould is spreading from the environment and infecting susceptible people's lungs, reveals a new study led by Imperial College London.
Proposal for assessing long COVID patients
26 April, 2022A new assessment proposal aimed at clinicians and researchers hopes to help to establish an individualised treatment protocol for long COVID patients.
